GCGR

GCGR

The G protein-coupled receptor family, which includes the glucagon receptor (GCGR), is crucial for regulating blood sugar levels. The class B G-protein coupled family of receptors includes the glucagon receptor, a 62 kDa protein that is activated by glucagon and coupled to G alpha i, Gs, and to a lesser extent G alpha q. Adenylate cyclase is activated and intracellular cAMP levels are raised when the receptor is stimulated. The GCGR gene in humans is responsible for encoding the glucagon receptor. The liver and kidneys are the primary sites of glucagon receptor expression, with smaller amounts of these receptors also present in the heart, adipose tissue, spleen, thymus, adrenal glands, pancreas, cerebral cortex, and gastrointestinal tract.

GCGR related products

Structure Cat No. Product Name CAS No. Product Description
V28800 Exendin-4 Acetate 914454-01-6 Exenatideacetate (Exendin-4 Acetate), a bioactive peptide composed of 39 amino acids, is antidiabetic medication acting as a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.
V79393 FC382K10W15 TFA FC382K10W15 TFA is a glucagon analog and GLP-1R/GCGR agonist.
V76995 FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS is an Exendin-4 polypeptide analogue.
V74589 GCGR antagonist 2 280134-25-0 GCGR antagonist 2 is a furan-2-carbohydrazide compound that is an orally bioactive glucagon receptor antagonist.
V74588 GIP/GLP-1 dual receptor agonist-1 2807481-02-1 GIP/GLP-1 dual receptor agonist-1 (compound 4) is a GIP/GLP-1 dual receptor agonist.
V74583 Glepaglutide (ZP1848) 914009-86-2 Glepaglutide (ZP1848), a long-acting GLP-2 analog, is a potent GLP-2R agonist.
V76977 Glepaglutide acetate (ZP1848 acetate) Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analog, is a potent GLP-2R agonist.
V79596 GLP-1 (1-36) amide (human, rat) (TFA) (Glucagon-like Peptide 1 (1-36) amide (human, rat) (TFA)) GLP-1 (1-36) amide (human, rat) (Glucagon-like Peptide 1 (1-36) amide (human, rat) TFA is glucagon-like peptide 1 (GLP-1)-(7-36 ) amide molecular variant.
V74565 GLP-1 moiety from Dulaglutide 1197810-60-8 GLP-1 moiety from Dulaglutide is a 31-amino acid (AA) fragment derived from Dulaglitude, a glucagon-like peptide 1 receptor (GLP-1) agonist, found in patent US 20160369010 A1.
V31513 GLP-1 receptor agonist 2 2230197-64-3 GLP-1 receptor agonist (activator) 2 is an agonist of the glucagon-like peptide receptor (GLP-1R).
V74591 GLP-1 receptor agonist 3 2230200-09-4 GLP-1 receptor agonist 3 (compound (R)-4A-1) is a potent and specific GLP-1 receptor agonist (WO2018109607A1) that may be utilized in diabetes research.
V74592 GLP-1 receptor agonist 4 1187061-62-6 GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist/activator with EC50 of 64.5 nM.
V74579 GLP-1 receptor agonist 7 2736447-04-2 GLP-1 receptor agonist 7 is a potent agonist of glucagon-like peptide-1 (GLP-1).
V74584 GLP-1 receptor agonist 8 2401892-86-0 GLP-1 receptor agonist 8 is a potent GLP-1 R agonist.
V74578 GLP-1 receptor agonist 9 2401892-71-3 GLP-1 receptor agonist (activator) 9 is a GLP-1 receptor agonist (activator), Example 7, developed from WO2020234726 A1.
V74569 GLP-1(28-36)amide 1225021-13-5 GLP-1(28-36)amide is a C-terminal nonapeptide of GLP-1 and is the main product of GLP-1 cleavage by a neutral endopeptidase (NEP).
V79598 GLP-1(28-36)amide TFA GLP-1(28-36)amide TFA is a C-terminal nonapeptide of GLP-1 and is the main product of GLP-1 cleavage by a neutral endopeptidase (NEP).
V74570 GLP-1(32-36)amide 1417302-71-6 GLP-1(32-36)amide, a pentapeptide extracted from the C-terminus of the sugar-regulating hormone GLP-1.
V79599 GLP-1(32-36)amide TFA GLP-1(32-36)amide TFA, a pentapeptide extracted from the C-terminus of the sugar-regulating hormone GLP-1.
V76974 GLP-1(7-36), amide TFA (Glucagon-like peptide-1 (GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA) GLP-1(7-36), amide TFA is a major intestinal hormone that prompts pancreatic beta cells to secrete insulin when stimulated by glucose.
Contact Us Back to top